Gastroparesis and Pregnancy: Managing Delayed Gastric Emptying While Expecting

Pregnancy and gastroparesis are a challenging combination. Pregnancy itself slows gastric emptying — progesterone relaxes smooth muscle throughout the GI tract, and the growing uterus physically compresses the stomach. For a patient who already has delayed gastric emptying, these physiological changes can transform manageable gastroparesis into a severe, debilitating condition that threatens both maternal and fetal nutrition.

Yet many patients with gastroparesis successfully navigate pregnancy with careful planning, the right medical team, and a flexible management strategy. This guide covers what to expect when gastroparesis meets pregnancy, which medications are safe, how to maintain adequate nutrition, and when more aggressive intervention is needed.

How Pregnancy Affects Gastric Emptying

Gastric emptying slows progressively throughout pregnancy, driven by several mechanisms:

Progesterone. Progesterone is the dominant hormone of pregnancy, and one of its primary functions is to relax smooth muscle — including the smooth muscle of the GI tract. This relaxation reduces the strength of gastric contractions, slows peristalsis, and delays gastric emptying. Progesterone levels rise throughout the first trimester and remain elevated until delivery.

Physical compression. As the uterus grows, it physically displaces and compresses the stomach, reducing its capacity and altering the angle of the gastroesophageal junction. By the third trimester, the stomach is significantly compressed, which can worsen symptoms of delayed emptying even in women without pre-existing gastroparesis.

Autonomic changes. Pregnancy causes significant changes in autonomic nervous system function, including increased heart rate, altered blood pressure regulation, and changes in vagal tone. In women with autonomic-mediated gastroparesis (as in POTS-associated gastroparesis), these autonomic changes can further impair gastric motility.

The result: Women with pre-existing gastroparesis typically experience significant worsening of symptoms during pregnancy, particularly in the first trimester (when nausea and vomiting of pregnancy are already at their peak) and the third trimester (when physical compression is greatest).

First Trimester: The Most Challenging Period

The first trimester is typically the most difficult period for pregnant women with gastroparesis. Nausea and vomiting of pregnancy (NVP) — which affects 70–80% of pregnant women — is superimposed on pre-existing gastroparesis, creating a perfect storm of symptoms.

Hyperemesis gravidarum (HG) — severe, persistent vomiting of pregnancy requiring medical intervention — occurs in 0.5–2% of pregnancies overall, but the rate is significantly higher in women with gastroparesis. HG can cause dangerous dehydration, electrolyte abnormalities, and weight loss that threatens fetal development.

Women with gastroparesis should be monitored closely in the first trimester and should have a low threshold for seeking medical attention if they cannot maintain adequate hydration and nutrition.

Medications: What Is Safe During Pregnancy

Medication management during pregnancy requires careful balancing of risks and benefits. Most prokinetic medications have limited safety data in pregnancy.

Metoclopramide (Reglan): FDA Pregnancy Category B (no evidence of risk in animal studies; adequate human studies lacking). Metoclopramide is the most commonly used prokinetic in pregnancy and is generally considered relatively safe, particularly in the first and second trimesters. It is also used for nausea and vomiting of pregnancy. The main concerns are the central nervous system side effects (tardive dyskinesia risk with prolonged use) and potential effects on fetal dopamine systems with long-term exposure. Short-term use for severe symptoms is generally accepted.

Domperidone: Not FDA-approved in the US; limited pregnancy safety data. Generally avoided in pregnancy due to insufficient data, though it is used in some countries. Discuss with your specialist.

Erythromycin: FDA Pregnancy Category B. Erythromycin is a motilin receptor agonist that stimulates gastric contractions. It is used short-term for gastroparesis flares. Concerns include antibiotic resistance with prolonged use and potential cardiac effects (QT prolongation). Generally considered acceptable for short-term use.

Ondansetron (Zofran): FDA Pregnancy Category B. Ondansetron is an antiemetic (not a prokinetic) that is widely used for nausea and vomiting of pregnancy. Some studies have raised concerns about a small increased risk of cardiac defects with first-trimester use, but the absolute risk is very small and the medication is generally considered acceptable when nausea is severe. It does not improve gastric emptying but can reduce nausea and vomiting.

Promethazine: FDA Pregnancy Category C. Used for nausea; causes sedation. Generally acceptable when other options have failed.

Medications to avoid in pregnancy:

• Domperidone (insufficient safety data)
• Cisapride (withdrawn from market; cardiac risks)
• Prucalopride (insufficient pregnancy data)

Nutritional Management During Pregnancy

Adequate nutrition is critical for fetal development, and maintaining it in the context of gastroparesis requires creative strategies:

Small, frequent meals. Eating 6–8 small meals per day (rather than 3 large ones) reduces the volume of food in the stomach at any given time, which is better tolerated by a stomach with delayed emptying.

Low-fat, low-fiber diet. Fat and fiber both slow gastric emptying. During pregnancy, when gastric emptying is already slowed, minimizing fat and fiber is particularly important. Focus on easily digestible carbohydrates, lean proteins, and well-cooked vegetables.

Liquid nutrition. When solid foods are not tolerated, liquid nutrition (smoothies, protein shakes, oral nutrition supplements like Ensure or Boost) can maintain caloric intake. Liquids empty from the stomach faster than solids, making them better tolerated in gastroparesis.

Eating position. Eating in an upright position and remaining upright for at least 2 hours after eating uses gravity to assist gastric emptying. Avoid lying flat after meals.

Hydration. Adequate hydration is critical during pregnancy and can be challenging with gastroparesis. Small, frequent sips of fluid throughout the day are better tolerated than large volumes at once. Electrolyte drinks (Pedialyte, Buoy Rescue Drops) can help maintain electrolyte balance when vomiting is frequent.

Weight monitoring. Regular weight monitoring is important to ensure adequate fetal nutrition. Weight gain targets during pregnancy are well-established; falling below these targets should prompt escalation of nutritional support.

When Hospitalization Is Needed

Some pregnant women with gastroparesis will require hospitalization for:

Severe dehydration. When oral hydration is not possible due to persistent vomiting, IV fluids are required. IV hydration can rapidly correct dehydration and electrolyte abnormalities and often provides significant symptom relief.

Nutritional failure. When oral and liquid nutrition cannot maintain adequate caloric intake and weight gain, more aggressive nutritional support is needed.

Enteral nutrition (tube feeding). A nasojejunal (NJ) tube — a thin tube passed through the nose, past the stomach, and into the small intestine — can provide nutrition that bypasses the stomach entirely. NJ feeding is well-tolerated during pregnancy and can maintain fetal nutrition when oral intake is inadequate.

Total parenteral nutrition (TPN). In severe cases where even enteral feeding is not tolerated, TPN (nutrition delivered directly into the bloodstream through a central IV line) may be required. TPN is a last resort due to its risks (infection, blood clots) but can be lifesaving when other options have failed.

Planning for Delivery

Women with gastroparesis should discuss their condition with their obstetric team before delivery:

Aspiration risk. Delayed gastric emptying increases the risk of aspiration (inhaling stomach contents) during anesthesia. The anesthesia team should be informed of the gastroparesis diagnosis before any procedure requiring anesthesia, including cesarean section.

Medication management during labor. Discuss with your gastroenterologist which medications to continue during labor and delivery.

Postpartum considerations. Gastroparesis symptoms typically improve after delivery as progesterone levels fall and the uterus no longer compresses the stomach. However, some women experience a postpartum flare, particularly if they had significant weight loss or nutritional compromise during pregnancy. Close monitoring in the postpartum period is important.